35 related articles for article (PubMed ID: 35575541)
1. Could the changes of immunity induced by SARS-CoV-2 infections explain the rebound of infectious disease after the relaxation of non-pharmaceutical interventions?
Cohen R; Levy C
Infect Dis Now; 2024 Feb; 54(1):104836. PubMed ID: 37984512
[No Abstract] [Full Text] [Related]
2. To: Critical COVID-19 and neurological dysfunction - a direct comparative analysis between SARS-CoV-2 and other infectious pathogens.
Finsterer J; Scorza FA
Crit Care Sci; 2023; 35(3):338-339. PubMed ID: 38133168
[No Abstract] [Full Text] [Related]
3. To: Critical COVID-19 and neurological dysfunction - a direct comparative analysis between SARS-CoV-2 and other infectious pathogens.
Magoon R; Suresh V
Crit Care Sci; 2023; 35(3):335-336. PubMed ID: 38133166
[No Abstract] [Full Text] [Related]
4. Reply to: Critical COVID-19 and neurological dysfunction - a direct comparative analysis between SARS-CoV-2 and other infectious pathogens.
Teixeira-Vaz A; Paiva JA
Crit Care Sci; 2023; 35(3):340-341. PubMed ID: 38133169
[No Abstract] [Full Text] [Related]
5. Reply to: Critical COVID-19 and neurological dysfunction - a direct comparative analysis between SARS-CoV-2 and other infectious pathogens.
Teixeira-Vaz A; Paiva JA
Crit Care Sci; 2023; 35(3):337. PubMed ID: 38133167
[No Abstract] [Full Text] [Related]
6. Infectious diseases in the COVID-19 era: gaps between countries.
Levy C; Cohen R
Lancet Infect Dis; 2023 Sep; 23(9):987-988. PubMed ID: 37141911
[No Abstract] [Full Text] [Related]
7. [Not Available].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2023 Nov; 66(11):1279-1301. PubMed ID: 37861707
[No Abstract] [Full Text] [Related]
8. COVID-19-an infectious disease in the top five causes of death in Australia.
Kirby T
Lancet Respir Med; 2023 Dec; 11(12):e102-e103. PubMed ID: 37956680
[No Abstract] [Full Text] [Related]
9. Metagenomic Next-Generation Sequencing (mNGS): SARS-CoV-2 as an Example of the Technology's Potential Pediatric Infectious Disease Applications.
Handel AS; Muller WJ; Planet PJ
J Pediatric Infect Dis Soc; 2021 Dec; 10(Supplement_4):S69-S70. PubMed ID: 34951468
[TBL] [Abstract][Full Text] [Related]
10. Infectious Disease Update: COVID-19 and Beyond.
Krilov LR
Pediatr Ann; 2022 May; 51(5):e178-e179. PubMed ID: 35575541
[No Abstract] [Full Text] [Related]
11. Does SARS-CoV-2 truly cause infectious myopathy?
Finsterer J; Scorza FA
J Formos Med Assoc; 2021 Mar; 120(3):1032-1033. PubMed ID: 32917481
[No Abstract] [Full Text] [Related]
12. What happened to infectious diseases and anti-infective therapy in 2020 beyond COVID-19?
Mormeneo Bayo S; García-Lechuz Moya JM
Rev Esp Quimioter; 2021 Sep; 34 Suppl 1(Suppl1):8-11. PubMed ID: 34598414
[TBL] [Abstract][Full Text] [Related]
13. How easy will it really be to replicate the success of the covid-19 vaccine with neglected infectious diseases?
Sahota R
BMJ; 2021 Mar; 372():n678. PubMed ID: 33692023
[No Abstract] [Full Text] [Related]
14. Response to letter to the editor "Does SARS-CoV-2 truly cause infectious myopathy?".
Chang KC
J Formos Med Assoc; 2021 Mar; 120(3):1034-1035. PubMed ID: 32921536
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
